Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 75
Filter
1.
Mol Cell Biol ; 30(1): 295-306, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19884348

ABSTRACT

An important difference between placental mammals and marsupials is the maturity of the fetus at birth. Placental mammals achieved this maturity by developing a complex and invasive placenta to support and prolong internal development. The exact genomic modifications that facilitated the evolution of this complex structure are unknown, but the emergence of genomic imprinting within mammalian lineages suggests a role for gene dosage. Here we show that a maximally altered placental structure is achieved by a single extra dose of the imprinted Phlda2 gene characterized by a dramatically reduced junctional zone and a decrease in stored glycogen. In addition, glycogen cells do not migrate into the maternal decidua in a timely fashion, but instead, Tpbpa-positive cells progressively mislocalize into the labyrinth. These defects are linked to a progressive restriction of embryonic growth from embryonic day 16.5. This work has identified a critical role for the imprinted Phlda2 gene in regulating glycogen storage in the eutherian placenta and implies that imprinting has provided a mechanism to boost nutrient supply to the fetus late in gestation, when the fetus is placing the highest demands on maternal resources, to enhance growth.


Subject(s)
Embryonic Development/physiology , Genomic Imprinting , Glycogen/metabolism , Nuclear Proteins/physiology , Placenta/physiology , Animals , Embryo Loss , Female , Mice , Mice, Transgenic , Nuclear Proteins/biosynthesis , Nuclear Proteins/genetics , Organ Size , Placenta/anatomy & histology , Placenta/cytology , Pregnancy , Trophoblasts/physiology
2.
Oncogene ; 27(34): 4657-65, 2008 Aug 07.
Article in English | MEDLINE | ID: mdl-18408767

ABSTRACT

Carcinoma is an altered state of tissue differentiation in which epithelial cells no longer respond to cues that keep them in their proper position. A break down in these cues has disastrous consequences not only in cancer but also in embryonic development when cells of various lineages must organize into discrete entities to form a body plan. Paraxial protocadherin (PAPC) is an adhesion protein with six cadherin repeats that organizes the formation and polarity of developing cellular structures in frog, fish and mouse embryos. Here we show that protocadherin-8 (PCDH8), the human ortholog of PAPC, is inactivated through either mutation or epigenetic silencing in a high fraction of breast carcinomas. Loss of PCDH8 expression is associated with loss of heterozygosity, partial promoter methylation, and increased proliferation. Complementation of mutant tumor cell line HCC2218 with wild-type PCDH8 inhibited its growth. Two tumor mutants, E146K and R343H, were defective for inhibition of cell growth and migration. Surprisingly, the E146K mutant transformed the human mammary epithelial cell line MCF10A and sustained the expression of cyclin D1 and MYC without epidermal growth factor. We propose that loss of PCDH8 promotes oncogenesis in epithelial human cancers by disrupting cell-cell communication dedicated to tissue organization and repression of mitogenic signaling.


Subject(s)
Breast Neoplasms/genetics , Cadherins/physiology , Genes, Tumor Suppressor/physiology , Animals , Base Sequence , Cadherins/genetics , Cadherins/metabolism , Cell Communication/genetics , Cell Movement/genetics , Cell Transformation, Neoplastic/genetics , DNA Methylation , DNA Mutational Analysis , Gene Deletion , Gene Expression Regulation, Neoplastic , Humans , Mammary Glands, Human/metabolism , Mice , Mutation , Promoter Regions, Genetic , Protocadherins , Sequence Homology, Nucleic Acid , Tumor Cells, Cultured
3.
Placenta ; 28(2-3): 77-84, 2007.
Article in English | MEDLINE | ID: mdl-16584773

ABSTRACT

Hypoxia influences gene expression in placental trophoblasts. We sought to examine the effect of hypoxia on trophoblast expression of human PHLDA2 (also termed IPL, TSSC3 or BWR-1C), a product of an imprinted gene on human chromosome 11p15.5 whose murine ortholog plays a pivotal role in placental development. We initially confirmed that PHLDA2 was expressed in term placental villi, primarily in the trophoblast layer. Using quantitative PCR we found that the expression of PHLDA2 gradually declined during differentiation of primary term human trophoblasts. A similar expression pattern was seen for p57(Kip2) and IGF-II, both products of imprinted genes on chromosome 11p15.5. Exposure of trophoblasts to hypoxia in vitro (O(2)

Subject(s)
Cyclin-Dependent Kinase Inhibitor p57/metabolism , Hypoxia/metabolism , Insulin-Like Growth Factor II/metabolism , Nuclear Proteins/metabolism , Trophoblasts/metabolism , Cells, Cultured , Humans
4.
Cytogenet Genome Res ; 113(1-4): 271-8, 2006.
Article in English | MEDLINE | ID: mdl-16575190

ABSTRACT

Genomic imprinting has a special role in placental biology. Imprinted genes are often strongly expressed in the placenta, and the allelic expression bias due to imprinting is sometimes stronger in this extraembryonic organ than in the embryo and adult. Mutations, epimutations, and uniparental disomies affecting imprinted loci cause placental stunting or overgrowth in mice and humans, and placental neoplasms (complete hydatidiform moles) are androgenetic. Whether imprinted genes might also play a role in the more common medical conditions that affect the placenta, including preeclampsia and intrauterine growth restriction (IUGR), is an important question that is now receiving some attention. Here we review this area and describe recent data indicating altered expression of imprinted genes in the placental response to maternal vascular underperfusion associated with IUGR.


Subject(s)
Genital Diseases, Female/genetics , Genomic Imprinting , Placenta/pathology , Placenta/physiology , Pregnancy Complications/genetics , Female , Fetal Growth Retardation/genetics , Gene Expression Regulation, Developmental , Humans , Pregnancy
5.
Placenta ; 27 Suppl A: S98-102, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16503350

ABSTRACT

Intrauterine growth and development can impact upon the long-term health of an individual. The fetus is dependent upon the placenta for its supply of nutrients and oxygen from the mother. In turn, the functional capacity of the placenta to supply that demand is under the control of the fetal and maternal genomes. Recent evidence suggests that imprinted genes, a class of genes found in placental mammals whose expression depends on their parental origin, have multiple roles in the placenta. The imprinted genes regulate the growth and transport capacity of the placenta, thereby controlling the supply of nutrients. They may also regulate the growth rate of fetal tissues directly, thereby controlling nutrient demand by the fetus. Recent studies using mice with deletions or disruption of imprinted genes with an altered balance between placental and fetal growth and changes in placental efficiency are indicative of feto-placental signalling of fetal nutrient demand. We propose that signalling mechanisms involving growth demand signals and nutrient transporters are likely to occur and are important for fine tuning normal fetal growth.


Subject(s)
Fetal Development/genetics , Gene Expression Regulation, Developmental , Genomic Imprinting , Placenta/metabolism , RNA-Binding Proteins/genetics , Animals , Female , Mice , Mice, Knockout , Placenta/blood supply , Placenta/embryology , Pregnancy
6.
Placenta ; 27(6-7): 540-9, 2006.
Article in English | MEDLINE | ID: mdl-16125225

ABSTRACT

Imprinted genes control fetal and placental growth in mice and in rare human syndromes, but the role of these genes in sporadic intrauterine growth restriction (IUGR) is less well-studied. We measured the ratio of mRNA from a maternally expressed imprinted gene, PHLDA2, to that from a paternally expressed imprinted gene, MEST, by Northern blotting in 38 IUGR-associated placentae and 75 non-IUGR placentae and found an increase in the PHLDA2/MEST mRNA ratio in IUGR (p=0.0001). Altered expression of PHLDA2 and MEST was not accompanied by changes in DNA methylation within their imprinting centers, and immunohistochemistry showed PHLDA2 protein appropriately restricted to villous and intermediate cytotrophoblast in the IUGR placentae. We next did a genome-wide survey of mRNA expression in 14 IUGR placentae with maternal vascular under-perfusion compared to 15 non-IUGR placentae using Affymetrix U133A microarrays. In this series six imprinted genes were differentially expressed by ANOVA with a Benjamini-Hochberg false discovery rate of 0.05, with increased expression of PHLDA2 and decreased expression of MEST, MEG3, GATM, GNAS and PLAGL1 in IUGR placentae. At lower significance, we found IGF2 mRNA decreased and CDKN1C mRNA increased in the IUGR cases. We confirmed the significant reduction in MEG3 non-translated RNA in IUGR placentae by Northern blotting. In addition to imprinted genes, the microarray data highlighted non-imprinted genes acting in endocrine signaling (LEP, CRH, HPGD, INHBA), tissue growth (IGF1), immune modulation (INDO, PSG-family genes), oxidative metabolism (GLRX), vascular function (AGTR1, DSCR1) and metabolite transport (SLC-family solute carriers) as differentially expressed in IUGR vs. non-IUGR placentae.


Subject(s)
Fetal Growth Retardation/genetics , Gene Expression Regulation, Developmental , Genomic Imprinting , Nuclear Proteins/genetics , Placenta/metabolism , Proteins/genetics , Adult , Blotting, Northern , Blotting, Southern , Female , Fetal Growth Retardation/metabolism , Gene Expression Profiling , Humans , Nuclear Proteins/metabolism , Oligonucleotide Array Sequence Analysis , Pregnancy , Proteins/metabolism , RNA, Messenger/metabolism
7.
Placenta ; 27(2-3): 119-26, 2006.
Article in English | MEDLINE | ID: mdl-16338457

ABSTRACT

The PEG1 gene (a.k.a. MEST) is expressed in human placental trophoblast and endothelium, and data from knockout mice show that this gene regulates placental and fetal growth. Isoform 1 of PEG1 mRNA initiates from exon 1c and produces the long form of the MEST protein. This isoform is imprinted, with expression only from the paternal allele in many human and mouse organs, including placenta. In contrast, PEG1 isoform 2, initiating from exon 1a and producing the short form of MEST protein, is biallelically expressed (non-imprinted) in several non-placental organs. Here we show that PEG1 isoform 2 is in fact imprinted in a large subset of human placentae. A CpG island overlapping PEG1 exon 1a is unmethylated in various fetal and adult non-placental tissues, but is often substantially methylated in the placenta, with the extent of methylation in a large series approximating a normal distribution. Bisulfite conversion/sequencing indicates that the inter-individual differences reflect the relative representation of heavily methylated vs. unmethylated alleles, and RT-PCR/RFLP analysis shows strongly biased allelic expression of PEG1 isoform 2 mRNA in a majority of placentae with a high proportion of methylated alleles. These data highlight PEG1 isoform 2 as a marker for future studies of inter-individual epigenetic variation and its relation to placental and fetal growth in humans.


Subject(s)
DNA Methylation , Epigenesis, Genetic , Genomic Imprinting , Placenta/metabolism , Proteins/genetics , Adult , Alleles , CpG Islands , DNA/analysis , DNA/metabolism , Exons , Female , Genetic Markers/genetics , Genetic Variation , Humans , Protein Isoforms/genetics , RNA, Messenger/analysis , RNA, Messenger/metabolism , Trophoblasts/chemistry , Trophoblasts/metabolism
8.
Neurology ; 63(5): 913-5, 2004 Sep 14.
Article in English | MEDLINE | ID: mdl-15365149

ABSTRACT

Using H2(15)O PET, the authors imaged 13 patients with Alzheimer disease (AD) while performing a serial nonverbal recognition memory task. Patterns of brain activation differed as a function of APOE genotype: epsilon4 carriers exhibited lower activation in the left lingual gyrus and higher activation in left cuneus, precuneus, parahippocampal, and right precentral gyrus. The APOE genotype seems to play a role in cerebral physiologic activity even after onset of clinical manifestations of AD.


Subject(s)
Alzheimer Disease/physiopathology , Apolipoproteins E/physiology , Brain Mapping , Brain/physiopathology , Positron-Emission Tomography , Age of Onset , Alleles , Alzheimer Disease/diagnostic imaging , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Apolipoprotein E4 , Apolipoproteins E/genetics , Brain/diagnostic imaging , Female , Genotype , Humans , Male , Memory Disorders/diagnostic imaging , Memory Disorders/genetics , Memory Disorders/physiopathology , Mental Recall , Middle Aged , Neuropsychological Tests , Pattern Recognition, Visual
9.
Mol Psychiatry ; 9(11): 1042-51, 2004 Nov.
Article in English | MEDLINE | ID: mdl-15241431

ABSTRACT

Familial Alzheimer's disease (AD [MIM 104300]) has been a focus of intense investigation, primarily in Caucasian families from Europe and North America families. Although the late-onset form of familial AD, beginning after age 65 years, has been linked to regions on chromosomes 10q and 12p, the specific genetic variants have not yet been consistently identified. Using a unique cohort of families of Caribbean Hispanics ancestry, we screened the genome using 340 markers on 490 family members from 96 families with predominantly late-onset AD. We observed the strongest support for linkage on 18q (LOD=3.14). However, 17 additional markers (chromosomes 1-6, 8, 10, 12, and 14) exceeded a two-point LOD score of 1.0 under the affecteds-only autosomal dominant model or affected sibpair model. As we previously reported the fine-mapping effort on 12p showing modest evidence of linkage, we focused our fine-mapping efforts on two other candidate regions in the current report, namely 10q and 18q. We added 31 family members and eight additional Caribbean Hispanic families to fine map 10q and 18q. With additional microsatellite markers, the evidence for linkage for 18q strengthened near 112 cM, where the two-point LOD score for D18S541 was 3.37 and the highest NPL score in that region was 3.65 (P=0.000177). This narrow region contains a small number of genes expressed in the brain. However, at 10q (134-138 cM), the NPL score decreased from 3.15 (P=0.000486) to 2.1 (P=0.0218), but two broad peaks remained overlapping with previously reported peaks. Our results provide modest support for linkage on 10q and 12p in this cohort of Caribbean Hispanic families with familial Alzheimer's disease, and strong evidence for a new locus on 18q.


Subject(s)
Alzheimer Disease/ethnology , Alzheimer Disease/genetics , Chromosomes, Human, Pair 10/genetics , Chromosomes, Human, Pair 18/genetics , Hispanic or Latino/genetics , Aged , Apolipoprotein E4 , Apolipoproteins E/genetics , Caribbean Region/ethnology , Chromosome Mapping , Chromosomes, Human, Pair 12/genetics , Dominican Republic/epidemiology , Female , Genetic Linkage/genetics , Genetic Predisposition to Disease , Genotype , Humans , Lod Score , Male , New York/epidemiology , Pedigree , Puerto Rico/epidemiology
10.
Neurology ; 62(3): 414-21, 2004 Feb 10.
Article in English | MEDLINE | ID: mdl-14872023

ABSTRACT

OBJECTIVE: To investigate the heritability of memory and other cognitive measures in families with multiple individuals with Alzheimer disease (AD) to determine if neuropsychological measures can be used to better understand genetic contributions to AD. METHODS: The genetic contributions to the variation in declarative memory, attention, abstract reasoning, language, and visuospatial function using a variance component method were estimated. For memory scores, the proportion of genetic contribution was estimated, controlling for APOE. RESULTS: The unadjusted heritability estimates for the declarative memory tasks ranged from 0.47 for delayed recall to 0.25 for delayed recognition, where a heritability estimate of 1 indicates that genetic factors explain all of the phenotypic variance and a heritability score of 0 indicates that genetic factors explain none. When adjusted for sex, age, education, and general intelligence, the heritability estimates increased to 0.60 for delayed recall and 0.41 for delayed recognition. None of the other cognitive tests showed heritability estimates as high as that observed for memory. When the influence of APOE was taken into account, the heritability estimates changed modestly for delayed recall and consistent long-term retrieval, whereas the estimates for other memory scores did not change, suggesting that APOE contributes little to these memory scores. CONCLUSIONS: Declarative memory in familial AD is under strong genetic influence, only part of which is attributable to APOE. Memory performance should prove to be a useful phenotypic component in the investigation of the genetic basis of AD.


Subject(s)
Alzheimer Disease/genetics , Apolipoproteins E/genetics , Membrane Proteins/genetics , Memory Disorders/genetics , Aged , Alleles , Alzheimer Disease/psychology , Amyloid beta-Protein Precursor/genetics , Caribbean Region , Dominican Republic , Family Health , Female , Genetic Predisposition to Disease , Genotype , Humans , Male , Memory Disorders/etiology , Middle Aged , Neuropsychological Tests , New York City , Presenilin-1 , Puerto Rico
11.
Placenta ; 24(8-9): 835-42, 2003.
Article in English | MEDLINE | ID: mdl-13129680

ABSTRACT

The IPL/TSSC3 gene is expressed nearly exclusively from the maternal allele, and its protein product acts to limit placental growth in mice. This protein specifically marks Type II trophoblast in the labyrinthine layer of the mouse placenta. To investigate mouse-human homologies, we carried out immunohistochemistry with antibodies against human IPL. There was strong expression of IPL in villous cytotrophoblast of the human placenta, contrasting with complete lack of expression in syncytiotrophoblast. Staining for IPL was weak in cells of the villous mesenchyme and extravillous trophoblast, including the cytotrophoblast columns in the basal plate and the intervillous trophoblast islands. The IPL and p57(KIP2)/CDKN1C genes are closely linked and coordinately imprinted, and immunostaining showed that their protein products are co-expressed in villous cytotrophoblast. However, other cell types, including extravillous cytotrophoblast and cells in various non-placental tissues, expressed p57(KIP2), but not IPL. IPL protein was absent in both of two cases of androgenetic complete hydatidiform mole examined by immunostaining, and IPL mRNA was absent in an additional three cases of this neoplasm examined by northern blotting. In the mouse, Ipl-expressing cells disappear at mid- to late-gestation when placental growth ceases, but persistent IPL mRNA and protein expression was observed throughout human gestation, correlating with the continuous growth of the human placenta. These findings highlight dosage regulation of human IPL by imprinting and, more generally, suggest homology between Type II labyrinthine trophoblast in the mouse and villous cytotrophoblast in humans, both of which are proliferative stem cell-like compartments.


Subject(s)
Chorionic Villi/metabolism , Hydatidiform Mole/metabolism , Nuclear Proteins/genetics , Nuclear Proteins/metabolism , Trophoblasts/metabolism , Uterine Neoplasms/metabolism , Amino Acid Sequence , Animals , Blotting, Northern , Blotting, Western , Cyclin-Dependent Kinase Inhibitor p57 , Female , Genomic Imprinting , Gestational Age , Humans , Hydatidiform Mole/genetics , Immunohistochemistry , Mice , Molecular Sequence Data , Nuclear Proteins/biosynthesis , Placenta/metabolism , Placentation , Pregnancy , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Tissue Distribution , Uterine Neoplasms/genetics
12.
Neurology ; 58(8): 1182-8, 2002 Apr 23.
Article in English | MEDLINE | ID: mdl-11971084

ABSTRACT

BACKGROUND: Psychiatric symptoms occur frequently in the course of AD, are a frequent contributor to institutionalization, predict cognitive decline and death, and often require treatment with psychotropic medications. Previous studies investigating the association between APOE genotype and psychiatric symptomatology in AD have reported contradictory results. OBJECTIVE: To determine whether APOE genotype predicts incident psychiatric symptomatology in patients with AD. METHODS: Eighty-seven patients with AD at early stages and no psychiatric history were followed semiannually for up to 9.3 years (mean 5.5 years) for development of delusions, illusions, hallucinations, behavioral symptoms, and depression. Cox proportional hazards models were used to examine the relative risk for incident psychiatric symptomatology (outcome) in relation to APOE genotype (predictor). RESULTS: The presence of one epsilon4 allele carried a 2.5-fold risk, whereas the presence of two epsilon4 alleles carried a 5.6-fold risk for development of delusions. The associations remained significant even when age, ethnicity, sex, education, duration of disease, and cognitive and functional performance were controlled for. The presence of two epsilon4 alleles was associated with reduced risk for developing hallucinations in the adjusted analysis only. No significant associations were detected between APOE genotype and the incidence of illusions, behavioral symptoms, or depression. CONCLUSION: The presence of one or more epsilon4 alleles is a significant predictor for the incidence of delusions in the course of AD.


Subject(s)
Alzheimer Disease/genetics , Alzheimer Disease/psychology , Apolipoproteins E/genetics , Aged , Alleles , Demography , Female , Humans , Male , Models, Psychological , Prospective Studies , Psychiatric Status Rating Scales , Risk Assessment
13.
Am J Hum Genet ; 70(1): 237-43, 2002 Jan.
Article in English | MEDLINE | ID: mdl-11715112

ABSTRACT

Linkage to chromosome 12p for familial Alzheimer disease (AD) has been inconsistent. Using 35 markers near the centromere of chromosome 12, we investigated 79 Caribbean Hispanic families with AD. Two-point linkage analysis using affected sib pairs yielded LOD scores of 3.15 at D12S1623 and 1.43 at D12S1042. The LOD score at D12S1623 decreased to 1.62 in families with late-onset (age >65 years) AD (LOAD), but the LOD score at D12S1042 was unchanged. Among families negative for the apolipoprotein E (APOE-epsilon 4) allele, the LOD score for D12S1623 was lower (1.01), whereas that for D12S1042 increased to 1.73. Among families positive for the APOE-epsilon 4 allele, none of the LOD scores reached 1. Multipoint affected-relative-pair analysis showed peaks at D12S1623 (nonparametric linkage [NPL] score 1.52; P=.028) and near D12S1042, at D12S1057 (NPL score 1.57; P=.027). NPL scores for both D12S1623 and D12S1057 increased in families affected with LOAD, but, in APOE-epsilon 4-negative families, only scores for the region flanking D12S1623 remained elevated (NPL score 1.74; P=.013). This study of Caribbean Hispanics with familial AD extends and provides modest evidence of linkage to loci on chromosome 12p. Linkage varied by age at onset of AD and by the presence or absence of the APOE-epsilon 4 allele.


Subject(s)
Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Chromosome Mapping , Chromosomes, Human, Pair 12/genetics , Hispanic or Latino/genetics , Adult , Age of Onset , Aged , Alleles , Alzheimer Disease/ethnology , Apolipoprotein E4 , Apolipoproteins E/genetics , Caribbean Region/epidemiology , Genetic Predisposition to Disease/genetics , Humans , Lod Score , Microsatellite Repeats/genetics
14.
JAMA ; 286(18): 2257-63, 2001 Nov 14.
Article in English | MEDLINE | ID: mdl-11710891

ABSTRACT

CONTEXT: Genetic determinants of Alzheimer disease (AD) have not been comprehensively examined in Caribbean Hispanics, a population in the United States in whom the frequency of AD is higher compared with non-Hispanic whites. OBJECTIVE: To identify variant alleles in genes related to familial early-onset AD among Caribbean Hispanics. DESIGN AND SETTING: Family-based case series conducted in 1998-2001 at an AD research center in New York, NY, and clinics in the Dominican Republic. PATIENTS: Among 206 Caribbean Hispanic families with 2 or more living members with AD who were identified, 19 (9.2%) had at least 1 individual with onset of AD before the age of 55 years. MAIN OUTCOME MEASURE: The entire coding region of the presenilin 1 gene and exons 16 and 17 of the amyloid precursor protein gene were sequenced in probands from the 19 families and their living relatives. RESULTS: A G-to-C nucleotide change resulting in a glycine-alanine amino acid substitution at codon 206 (Gly206Ala) in exon 7 of presenilin 1 was observed in 23 individuals from 8 (42%) of the 19 families. A Caribbean Hispanic individual with the Gly206Ala mutation and early-onset familial disease was also found by sequencing the corresponding genes of 319 unrelated individuals in New York City. The Gly206Ala mutation was not found in public genetic databases but was reported in 5 individuals from 4 Hispanic families with AD referred for genetic testing. None of the members of these families were related to one another, yet all carriers of the Gly206Ala mutation tested shared a variant allele at 2 nearby microsatellite polymorphisms, indicating a common ancestor. No mutations were found in the amyloid precursor protein gene. CONCLUSIONS: The Gly206Ala mutation was found in 8 of 19 unrelated Caribbean Hispanic families with early-onset familial AD. This genetic change may be a prevalent cause of early-onset familial AD in the Caribbean Hispanic population.


Subject(s)
Alzheimer Disease/genetics , Hispanic or Latino/genetics , Membrane Proteins/genetics , Age of Onset , Aged , Alanine , Alzheimer Disease/epidemiology , Amyloid beta-Protein Precursor/genetics , Apolipoproteins E/genetics , Caribbean Region/ethnology , DNA Mutational Analysis , Dominican Republic/ethnology , Exons , Genotype , Glycine , Haplotypes , Humans , Microsatellite Repeats , Middle Aged , Mutation , Phenotype , Polymorphism, Genetic , Presenilin-1 , Puerto Rico/ethnology , United States/epidemiology
15.
Am J Med Genet ; 103(2): 121-7, 2001 Oct 01.
Article in English | MEDLINE | ID: mdl-11568917

ABSTRACT

To investigate whether mortality risk is influenced by apolipoprotein E (APOE) genotype and whether the risk differs by ethnicity, we compared the mortality risk in 2,112 individuals > or = 65 years of age residing in northern Manhattan in New York. Mortality risks associated with the APOE genotype, adjusted for sex, high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglycerides, differed significantly by ethnic group. Among Caucasian and Hispanics, the E2/E3 genotype was associated with the lowest mortality risk in the multivariate Cox proportional hazards modeling, adjusted for lipid levels, whereas mortality risk did not differ substantially between the E4/E3 and E3/E3 genotypes. Among African-Americans, the E2/E3 genotype was not associated with the lowest mortality risk, but the E4/E3 genotype was. Adjustment for heart disease, diabetes, and stroke reduced mortality risk associated with each genotype by about 50% for all ethnic groups, but the patterns remained the same. Although we cannot rule out the possibility of a healthy survival bias, our analyses designed to examine healthy survival by comparing risk of mortality in groups who were younger or older at entry do not support this possibility. Our findings suggest that the APOE genotype is associated with mortality and that the genotypic risks differ by ethnic group. Nearly 50% of the mortality risk associated with the APOE genotype appears to act through major chronic diseases, but those diseases only partially explain the mechanism by which the genotypic risk acts. To better understand the observed ethnic differences in mortality risk by genotype, a detailed prospective study is needed to examine the relationships among APOE, other candidate genes, health conditions, and eventual death.


Subject(s)
Apolipoproteins E/genetics , Mortality , Aged , Alleles , Black People/genetics , DNA/genetics , Female , Gene Frequency , Genotype , Hispanic or Latino/genetics , Humans , Male , Survival Analysis , Survival Rate , White People/genetics
16.
Neurobiol Aging ; 22(4): 683-9, 2001.
Article in English | MEDLINE | ID: mdl-11445269

ABSTRACT

Transgenic mice expressing human APOE-epsilon4 develop an age-dependent decline in memory without pathological features of Alzheimer's disease (AD). This implicates APOE in the maintenance of memory during normal senescence, but parallel human studies are limited because longitudinal investigations of memory usually do not exclude patients with AD or "questionable" AD (QD). The current study examined the effect of APOE on cognitive function over time in elderly without dementia. We hypothesized that, compared to other APOE alleles memory decline even in healthy elderly would be greater among those with an APOE-epsilon4. The results of neuropsychological tests, grouped into domains of memory, language and visuospatial/cognitive function by factor analysis, were examined at three intervals over a seven-year period in 563 healthy elderly without AD or QD using generalized estimating equations. Memory performance declined over time, while scores on the visuospatial/cognitive and language factors did not change. Increased age was associated with lower scores, and higher education with higher scores on all factors at each interval. No APOE allele was associated with performance on a specific cognitive factor at any interval, but the presence of an APOE-epsilon4 allele was associated with a more rapid decline in the memory factor over the follow-up period. The effect was most pronounced among individuals with less than 10 years of formal education. There was no similar time-dependent relationship between APOE-epsilon4 and the language or visuospatial/cognitive factors. Transgenic mice and elderly humans without AD or QD expressing APOE-epsilon4 show a decline in memory performance over time. These observations provide evidence for an APOE-specific effect on memory during senescence.


Subject(s)
Aging/physiology , Apolipoproteins E/genetics , Cognition/physiology , Memory/physiology , Aged , Aged, 80 and over , Alzheimer Disease , Apolipoprotein E4 , Female , Follow-Up Studies , Humans , Longitudinal Studies , Male , Neuropsychological Tests
17.
Biochem Biophys Res Commun ; 283(5): 1124-30, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11355889

ABSTRACT

Genomic imprinting is the phenomenon by which the two alleles of certain genes are differentially expressed according to their parental origin. Extensive analysis of allelic expression at multiple imprinted loci in a normal population has not performed so far. In the present study, we examined the allelic expression pattern of three imprinted genes in a panel of 262 Japanese normal individuals. We observed differences in the extent of maintenance of allele-specific expression of the three genes. The allelic expression of small nuclear ribonucleoprotein N (SNRPN) was stringently regulated while that of multimembrane-spanning polyspecific transporter-like gene 1 (IMPT1) showed a large degree of variation. Significant biallelic expression of insulin-like growth factor II (IGF2) was observed in about 10% of normal individuals. Our findings add to the accumulating evidence for variable allelic expression at multiple loci in a normal human population. This epigenetic heterogeneity can be a stable trait and potentially influence individual phenotypes.


Subject(s)
Autoantigens/genetics , Genetic Variation , Genomic Imprinting , Insulin-Like Growth Factor II/genetics , Membrane Proteins/genetics , Organic Cation Transport Proteins , Alleles , DNA/blood , Female , Gene Expression Regulation , Humans , Japan , Leukocytes/metabolism , Male , Pedigree , Polymerase Chain Reaction , Ribonucleoproteins, Small Nuclear/genetics , snRNP Core Proteins
18.
Neurosci Lett ; 301(3): 199-203, 2001 Apr 06.
Article in English | MEDLINE | ID: mdl-11257432

ABSTRACT

We compared levels of plasma amyloid beta-peptides Abeta1-42 and Abeta1-40 in 108 demented and nondemented adults with Down syndrome (DS) and 64 adults from the general population. Abeta1-42 and Abeta1-40 levels were significantly higher in adults with DS than in controls (P=0.0001). Compared to nondemented adults with DS, Abeta1-42 levels in demented adults with DS were selectively increased by 26% (28.2 pg/ml vs. 22.4 pg/ml, P=0.004). In addition, mean plasma levels of Abeta1-42 were 22% higher in DS cases with the apolipoprotein varepsilon4 allele than in DS subjects without an varepsilon4 allele (25.9 pg/ml vs. 21.2 pg/ml, P=0.01), while mean plasma levels of Abeta1-40 did not vary by APOE genotype. These results support the hypothesis that Abeta1-42 plays an important role in the pathogenesis of dementia associated with DS, as it does in Alzheimer's disease, and that variations in plasma levels may be related to disease progression.


Subject(s)
Alzheimer Disease/blood , Amyloid beta-Peptides/blood , Down Syndrome/blood , Peptide Fragments/blood , Adult , Alleles , Alzheimer Disease/genetics , Apolipoprotein E4 , Apolipoproteins E/genetics , Disease Progression , Down Syndrome/genetics , Female , Humans , Male , Middle Aged
19.
Neurology ; 55(10): 1536-9, 2000 Nov 28.
Article in English | MEDLINE | ID: mdl-11094110

ABSTRACT

OBJECTIVE: APOE epsilon4 has been associated with late-onset familial and sporadic AD and delayed recovery from head injury. The authors examined the relationship between functional recovery of patients with head injury and the APOE alleles. METHODS: Thirty-one patients with head injury who had completed the Acute Neurorehabilitation Program at Helen Hayes Hospital were evaluated for presence of APOE epsilon4 and assessed for recovery based on Functional Independence Measures (FIM). RESULTS: Analysis of covariance (using coma days as the covariate to control for differences in initial severity of injury between subjects with and without APOE epsilon4) revealed a significant difference for both total FIM and motor FIM scores between the subjects with and without APOE epsilon4. Specifically, there were lower scores for total FIM (df = 30; F = 3.341; p = 0.05) and motor FIM (df = 30; F = 4.189; p = 0.026) in APOE epsilon4 carriers. No difference was found for the cognitive portion of the FIM. CONCLUSIONS: The data suggest that the presence of the lipoprotein APOE epsilon4 adversely affects rehabilitation outcome for traumatic brain injury survivors.


Subject(s)
Apolipoproteins E/genetics , Brain Injuries/genetics , Brain Injuries/rehabilitation , Adult , Alleles , Female , Humans , Male , Middle Aged , Prognosis , Retrospective Studies , Time Factors
20.
Arch Neurol ; 57(10): 1454-7, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11030797

ABSTRACT

Two children of an adult with early-onset, autopsy-confirmed Alzheimer disease (AD) developed dementia in their late 20s and were subsequently found to have novel mutations in codon 434 of the presenilin 1 (PS1) gene on chromosome 14, a G-to-T substitution at nucleotide 1548 and a C-to-G substitution at nucleotide 1549. The younger of the 2 children had AD confirmed at postmortem examination. The disease course in these 3 individuals was characterized by cognitive and behavioral problems accompanied by myoclonus, seizures, and aphasia within 5 years after onset. Two grandparents had clinically diagnosed AD with stroke beginning at ages 78 and 66 years, but neither had a PS1 mutation. No other living family member was demented, nor did any other family member have the PS1 mutation. We conclude that the affected parent of the proband was a likely recent founder for these novel mutations in PS1. The family demonstrates the clinical and genetic heterogeneity of AD. Arch Neurol. 2000;57:1454-1457


Subject(s)
Alzheimer Disease/genetics , Membrane Proteins/genetics , Point Mutation/genetics , Adult , Age Distribution , Age of Onset , Aged , Alzheimer Disease/epidemiology , Alzheimer Disease/metabolism , Apolipoproteins E/metabolism , Chromosome Aberrations/genetics , Chromosome Disorders , Chromosomes, Human, Pair 14/genetics , Codon/genetics , DNA Mutational Analysis , Female , Humans , Male , Neurofibrillary Tangles/metabolism , Pedigree , Presenilin-1
SELECTION OF CITATIONS
SEARCH DETAIL
...